Global Gonadotropin-releasing Hormone Agonist Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gonadotropin-releasing Hormone Agonist Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Gonadotropin-releasing Hormone Agonist Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Gonadotropin-releasing Hormone Agonist Drugs by Country/Region, 2017, 2022 & 2028

2.2 Gonadotropin-releasing Hormone Agonist Drugs Segment by Type

2.2.1 Leuprorelin

2.2.2 Goserelin

2.2.3 Taltirelin

2.2.4 Histrelin

2.2.5 Other

2.3 Gonadotropin-releasing Hormone Agonist Drugs Sales by Type

2.3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Gonadotropin-releasing Hormone Agonist Drugs Sale Price by Type (2017-2022)

2.4 Gonadotropin-releasing Hormone Agonist Drugs Segment by Application

2.4.1 Hospital

2.4.2 Pharmacy

2.4.3 Other

2.5 Gonadotropin-releasing Hormone Agonist Drugs Sales by Application

2.5.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Gonadotropin-releasing Hormone Agonist Drugs Sale Price by Application (2017-2022)

3 Global Gonadotropin-releasing Hormone Agonist Drugs by Company

3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Breakdown Data by Company

3.1.1 Global Gonadotropin-releasing Hormone Agonist Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company (2020-2022)

3.2 Global Gonadotropin-releasing Hormone Agonist Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Company (2020-2022)

3.2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Gonadotropin-releasing Hormone Agonist Drugs Sale Price by Company

3.4 Key Manufacturers Gonadotropin-releasing Hormone Agonist Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Gonadotropin-releasing Hormone Agonist Drugs Product Location Distribution

3.4.2 Players Gonadotropin-releasing Hormone Agonist Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Gonadotropin-releasing Hormone Agonist Drugs by Geographic Region

4.1 World Historic Gonadotropin-releasing Hormone Agonist Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Gonadotropin-releasing Hormone Agonist Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Gonadotropin-releasing Hormone Agonist Drugs Annual Revenue by Geographic Region

4.2 World Historic Gonadotropin-releasing Hormone Agonist Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Annual Revenue by Country/Region

4.3 Americas Gonadotropin-releasing Hormone Agonist Drugs Sales Growth

4.4 APAC Gonadotropin-releasing Hormone Agonist Drugs Sales Growth

4.5 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Growth

4.6 Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Growth

5 Americas

5.1 Americas Gonadotropin-releasing Hormone Agonist Drugs Sales by Country

5.1.1 Americas Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2017-2022)

5.1.2 Americas Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2017-2022)

5.2 Americas Gonadotropin-releasing Hormone Agonist Drugs Sales by Type

5.3 Americas Gonadotropin-releasing Hormone Agonist Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gonadotropin-releasing Hormone Agonist Drugs Sales by Region

6.1.1 APAC Gonadotropin-releasing Hormone Agonist Drugs Sales by Region (2017-2022)

6.1.2 APAC Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region (2017-2022)

6.2 APAC Gonadotropin-releasing Hormone Agonist Drugs Sales by Type

6.3 APAC Gonadotropin-releasing Hormone Agonist Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Gonadotropin-releasing Hormone Agonist Drugs by Country

7.1.1 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2017-2022)

7.1.2 Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2017-2022)

7.2 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Type

7.3 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs by Country

8.1.1 Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Type

8.3 Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Gonadotropin-releasing Hormone Agonist Drugs

10.3 Manufacturing Process Analysis of Gonadotropin-releasing Hormone Agonist Drugs

10.4 Industry Chain Structure of Gonadotropin-releasing Hormone Agonist Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Gonadotropin-releasing Hormone Agonist Drugs Distributors

11.3 Gonadotropin-releasing Hormone Agonist Drugs Customer

12 World Forecast Review for Gonadotropin-releasing Hormone Agonist Drugs by Geographic Region

12.1 Global Gonadotropin-releasing Hormone Agonist Drugs Market Size Forecast by Region

12.1.1 Global Gonadotropin-releasing Hormone Agonist Drugs Forecast by Region (2023-2028)

12.1.2 Global Gonadotropin-releasing Hormone Agonist Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Gonadotropin-releasing Hormone Agonist Drugs Forecast by Type

12.7 Global Gonadotropin-releasing Hormone Agonist Drugs Forecast by Application

13 Key Players Analysis

13.1 AbbVie

13.1.1 AbbVie Company Information

13.1.2 AbbVie Gonadotropin-releasing Hormone Agonist Drugs Product Offered

13.1.3 AbbVie Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AbbVie Main Business Overview

13.1.5 AbbVie Latest Developments

13.2 AstraZeneca

13.2.1 AstraZeneca Company Information

13.2.2 AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Product Offered

13.2.3 AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AstraZeneca Main Business Overview

13.2.5 AstraZeneca Latest Developments

13.3 Ferring

13.3.1 Ferring Company Information

13.3.2 Ferring Gonadotropin-releasing Hormone Agonist Drugs Product Offered

13.3.3 Ferring Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Ferring Main Business Overview

13.3.5 Ferring Latest Developments

13.4 TerSera Therapeutics

13.4.1 TerSera Therapeutics Company Information

13.4.2 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Product Offered

13.4.3 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 TerSera Therapeutics Main Business Overview

13.4.5 TerSera Therapeutics Latest Developments

13.5 Takeda

13.5.1 Takeda Company Information

13.5.2 Takeda Gonadotropin-releasing Hormone Agonist Drugs Product Offered

13.5.3 Takeda Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Takeda Main Business Overview

13.5.5 Takeda Latest Developments

13.6 LIVZON

13.6.1 LIVZON Company Information

13.6.2 LIVZON Gonadotropin-releasing Hormone Agonist Drugs Product Offered

13.6.3 LIVZON Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 LIVZON Main Business Overview

13.6.5 LIVZON Latest Developments

13.7 Ipsen

13.7.1 Ipsen Company Information

13.7.2 Ipsen Gonadotropin-releasing Hormone Agonist Drugs Product Offered

13.7.3 Ipsen Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Ipsen Main Business Overview

13.7.5 Ipsen Latest Developments

13.8 Sanofi

13.8.1 Sanofi Company Information

13.8.2 Sanofi Gonadotropin-releasing Hormone Agonist Drugs Product Offered

13.8.3 Sanofi Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sanofi Main Business Overview

13.8.5 Sanofi Latest Developments

13.9 Endo

13.9.1 Endo Company Information

13.9.2 Endo Gonadotropin-releasing Hormone Agonist Drugs Product Offered

13.9.3 Endo Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Endo Main Business Overview

13.9.5 Endo Latest Developments

14 Research Findings and Conclusion

Table 1. Gonadotropin-releasing Hormone Agonist Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Gonadotropin-releasing Hormone Agonist Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Leuprorelin

Table 4. Major Players of Goserelin

Table 5. Major Players of Taltirelin

Table 6. Major Players of Histrelin

Table 7. Major Players of Other

Table 8. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2017-2022) & (K Units)

Table 9. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2017-2022)

Table 10. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Type (2017-2022) & ($ million)

Table 11. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Type (2017-2022)

Table 12. Global Gonadotropin-releasing Hormone Agonist Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 13. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2017-2022) & (K Units)

Table 14. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2017-2022)

Table 15. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Application (2017-2022)

Table 16. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Application (2017-2022)

Table 17. Global Gonadotropin-releasing Hormone Agonist Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 18. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Company (2020-2022) & (K Units)

Table 19. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Company (2020-2022)

Table 20. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Company (2020-2022)

Table 22. Global Gonadotropin-releasing Hormone Agonist Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 23. Key Manufacturers Gonadotropin-releasing Hormone Agonist Drugs Producing Area Distribution and Sales Area

Table 24. Players Gonadotropin-releasing Hormone Agonist Drugs Products Offered

Table 25. Gonadotropin-releasing Hormone Agonist Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share Geographic Region (2017-2022)

Table 30. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country/Region (2017-2022)

Table 34. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2017-2022) & (K Units)

Table 37. Americas Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2017-2022)

Table 38. Americas Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2017-2022)

Table 40. Americas Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2017-2022) & (K Units)

Table 41. Americas Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2017-2022)

Table 42. Americas Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2017-2022) & (K Units)

Table 43. Americas Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2017-2022)

Table 44. APAC Gonadotropin-releasing Hormone Agonist Drugs Sales by Region (2017-2022) & (K Units)

Table 45. APAC Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region (2017-2022)

Table 46. APAC Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Region (2017-2022)

Table 48. APAC Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2017-2022) & (K Units)

Table 49. APAC Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2017-2022)

Table 50. APAC Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2017-2022) & (K Units)

Table 51. APAC Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2017-2022)

Table 52. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2017-2022) & (K Units)

Table 53. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2017-2022)

Table 54. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2017-2022)

Table 56. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2017-2022) & (K Units)

Table 57. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2017-2022)

Table 58. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2017-2022) & (K Units)

Table 59. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Gonadotropin-releasing Hormone Agonist Drugs

Table 69. Key Market Challenges & Risks of Gonadotropin-releasing Hormone Agonist Drugs

Table 70. Key Industry Trends of Gonadotropin-releasing Hormone Agonist Drugs

Table 71. Gonadotropin-releasing Hormone Agonist Drugs Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Gonadotropin-releasing Hormone Agonist Drugs Distributors List

Table 74. Gonadotropin-releasing Hormone Agonist Drugs Customer List

Table 75. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Forecast by Region

Table 77. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Gonadotropin-releasing Hormone Agonist Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Gonadotropin-releasing Hormone Agonist Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Gonadotropin-releasing Hormone Agonist Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Gonadotropin-releasing Hormone Agonist Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 95. AbbVie Basic Information, Gonadotropin-releasing Hormone Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 96. AbbVie Gonadotropin-releasing Hormone Agonist Drugs Product Offered

Table 97. AbbVie Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 98. AbbVie Main Business

Table 99. AbbVie Latest Developments

Table 100. AstraZeneca Basic Information, Gonadotropin-releasing Hormone Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 101. AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Product Offered

Table 102. AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 103. AstraZeneca Main Business

Table 104. AstraZeneca Latest Developments

Table 105. Ferring Basic Information, Gonadotropin-releasing Hormone Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 106. Ferring Gonadotropin-releasing Hormone Agonist Drugs Product Offered

Table 107. Ferring Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 108. Ferring Main Business

Table 109. Ferring Latest Developments

Table 110. TerSera Therapeutics Basic Information, Gonadotropin-releasing Hormone Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 111. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Product Offered

Table 112. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 113. TerSera Therapeutics Main Business

Table 114. TerSera Therapeutics Latest Developments

Table 115. Takeda Basic Information, Gonadotropin-releasing Hormone Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 116. Takeda Gonadotropin-releasing Hormone Agonist Drugs Product Offered

Table 117. Takeda Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 118. Takeda Main Business

Table 119. Takeda Latest Developments

Table 120. LIVZON Basic Information, Gonadotropin-releasing Hormone Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 121. LIVZON Gonadotropin-releasing Hormone Agonist Drugs Product Offered

Table 122. LIVZON Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 123. LIVZON Main Business

Table 124. LIVZON Latest Developments

Table 125. Ipsen Basic Information, Gonadotropin-releasing Hormone Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 126. Ipsen Gonadotropin-releasing Hormone Agonist Drugs Product Offered

Table 127. Ipsen Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 128. Ipsen Main Business

Table 129. Ipsen Latest Developments

Table 130. Sanofi Basic Information, Gonadotropin-releasing Hormone Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 131. Sanofi Gonadotropin-releasing Hormone Agonist Drugs Product Offered

Table 132. Sanofi Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 133. Sanofi Main Business

Table 134. Sanofi Latest Developments

Table 135. Endo Basic Information, Gonadotropin-releasing Hormone Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 136. Endo Gonadotropin-releasing Hormone Agonist Drugs Product Offered

Table 137. Endo Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 138. Endo Main Business

Table 139. Endo Latest Developments

List of Figures

Figure 1. Picture of Gonadotropin-releasing Hormone Agonist Drugs

Figure 2. Gonadotropin-releasing Hormone Agonist Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Gonadotropin-releasing Hormone Agonist Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Leuprorelin

Figure 10. Product Picture of Goserelin

Figure 11. Product Picture of Taltirelin

Figure 12. Product Picture of Histrelin

Figure 13. Product Picture of Other

Figure 14. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type in 2021

Figure 15. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Type (2017-2022)

Figure 16. Gonadotropin-releasing Hormone Agonist Drugs Consumed in Hospital

Figure 17. Global Gonadotropin-releasing Hormone Agonist Drugs Market: Hospital (2017-2022) & (K Units)

Figure 18. Gonadotropin-releasing Hormone Agonist Drugs Consumed in Pharmacy

Figure 19. Global Gonadotropin-releasing Hormone Agonist Drugs Market: Pharmacy (2017-2022) & (K Units)

Figure 20. Gonadotropin-releasing Hormone Agonist Drugs Consumed in Other

Figure 21. Global Gonadotropin-releasing Hormone Agonist Drugs Market: Other (2017-2022) & (K Units)

Figure 22. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2017-2022)

Figure 23. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Application in 2021

Figure 24. Gonadotropin-releasing Hormone Agonist Drugs Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Company in 2021

Figure 26. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Geographic Region in 2021

Figure 28. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region (2017-2022)

Figure 29. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country/Region in 2021

Figure 30. Americas Gonadotropin-releasing Hormone Agonist Drugs Sales 2017-2022 (K Units)

Figure 31. Americas Gonadotropin-releasing Hormone Agonist Drugs Revenue 2017-2022 ($ Millions)

Figure 32. APAC Gonadotropin-releasing Hormone Agonist Drugs Sales 2017-2022 (K Units)

Figure 33. APAC Gonadotropin-releasing Hormone Agonist Drugs Revenue 2017-2022 ($ Millions)

Figure 34. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales 2017-2022 (K Units)

Figure 35. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales 2017-2022 (K Units)

Figure 37. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue 2017-2022 ($ Millions)

Figure 38. Americas Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country in 2021

Figure 39. Americas Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country in 2021

Figure 40. United States Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region in 2021

Figure 45. APAC Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Regions in 2021

Figure 46. China Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country in 2021

Figure 53. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country in 2021

Figure 54. Germany Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country in 2021

Figure 61. Egypt Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Gonadotropin-releasing Hormone Agonist Drugs in 2021

Figure 67. Manufacturing Process Analysis of Gonadotropin-releasing Hormone Agonist Drugs

Figure 68. Industry Chain Structure of Gonadotropin-releasing Hormone Agonist Drugs

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles